The vagina as a route for drug delivery: a review

  title={The vagina as a route for drug delivery: a review},
  author={S. Srikrishna and L. Cardozo},
  journal={International Urogynecology Journal},
  • S. Srikrishna, L. Cardozo
  • Published 2012
  • Medicine
  • International Urogynecology Journal
  • Overactive bladder (OAB) syndrome has a significant deleterious impact on quality of life. After conservative therapy and bladder retaining, antimuscarinic drugs remain the mainstay of OAB management. Oral therapy is associated with frequent side effects, leading to the development of alternative agents and formulations or the use of novel routes of drug administration, such as the vaginal route. The vagina is often ideal for drug delivery because it allows the use of lower doses, maintains… CONTINUE READING
    38 Citations
    Modifications in Vaginal Microbiota and Their Influence on Drug Release: Challenges and Opportunities
    • 11
    • PDF
    Mucosal delivery systems of antihypertensive drugs: A practical approach in general practice.
    • 5
    • PDF
    Female reproductive tract pain: targets, challenges, and outcomes
    • 6
    • PDF
    Topical Inserts: A Versatile Delivery Form for HIV Prevention
    • 7
    • PDF
    Topical drug delivery systems: a patent review
    • 55


    Drug delivery by the intravaginal route.
    • 117
    Development of a Mucoadhesive Dosage Form for Vaginal Administration
    • 70
    Vaginal ring delivery of hormone replacement therapy – a review
    • 42
    Oxybutynin: past, present, and future
    • 22
    Effectiveness of vaginally administered oxybutynin on rabbit bladder function.
    • 14
    Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis.
    • 66
    • PDF
    Propranolol concentrations in plasma after insertion into the vagina.
    • 41
    • PDF
    Vaginal Bromocriptine: Pharmacology and Effect on Serum Prolactin in Normal Women
    • 49